STAT News' Adam Feuerstein On Benzinga's PreMarket Prep Says 'Something like [Biogen Alzheimer's news] could get people more interested in the larger cap [biotech stocks], like a Biogen,' But Again Warns Of Cautiousness In General Moving Forward